65 results on '"Lederer, David J"'
Search Results
2. Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals
3. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant
4. A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis
5. A novel patient‐centered “intention‐to‐treat” metric of U.S. lung transplant center performance
6. High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults
7. Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
8. AnnalsATS 2022: Rigor, Value, Impact
9. Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis)
10. A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective
11. Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies
12. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension
13. Patient-centered Outcomes in Idiopathic Pulmonary Fibrosis Clinical Trials
14. Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation
15. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
16. Cryobiopsy in the Diagnosis of Interstitial Lung Disease. A Step Forward or Back?
17. Short Stature and Access to Lung Transplantation in the United States. A Cohort Study
18. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension
19. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation
20. Editorsʼ Introduction to AnnalsATS Clinical Research Design Articles
21. Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis
22. Survival of Adults With Systemic Sclerosis Following Lung Transplantation: A Nationwide Cohort Study
23. Interleukin-6 and Tumor Necrosis Factor-α Are Associated with Quality of Life-Related Symptoms in Pulmonary Arterial Hypertension
24. Body Composition and Mortality after Adult Lung Transplantation in the United States
25. Embracing Complex Diseases. The Case for an Idiopathic Pulmonary Fibrosis Biorepository
26. One-Year Survival of Adults with Systemic Sclerosis Following Lung Transplantation: A Nationwide Cohort Study.: 1797
27. Plasma Complement Levels Are Associated with Primary Graft Dysfunction and Mortality after Lung Transplantation
28. The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors☆
29. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
30. Interstitial Lung Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
31. Genetic Variation in the Prostaglandin E2 Pathway Is Associated with Primary Graft Dysfunction
32. High Burden of Palliative Needs among Older Intensive Care Unit Survivors Transferred to Post-Acute Care Facilities. A Single-Center Study
33. Latent Class Analysis Identifies Distinct Phenotypes of Primary Graft Dysfunction After Lung Transplantation
34. Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
35. An Acute Change in Lung Allocation Score and Survival After Lung Transplantation: A Cohort Study
36. A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness
37. Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
38. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation
39. Socioeconomic Barriers to Lung Transplantation: Balancing Access and Equity
40. Variation in PTX3 Is Associated with Primary Graft Dysfunction after Lung Transplantation
41. Plasma Endothelin-1 and Vascular Endothelial Growth Factor Levels and Their Relationship to Hemodynamics in Idiopathic Pulmonary Fibrosis
42. Secondary Prevention of Idiopathic Pulmonary Fibrosis: Catching the Horse Still in the Barn
43. Two, One, or None for Chronic Obstructive Pulmonary Disease: Who Decides and How?
44. Obesity and Primary Graft Dysfunction after Lung Transplantation: The Lung Transplant Outcomes Group Obesity Study
45. Delayed Access and Survival in Idiopathic Pulmonary Fibrosis: A Cohort Study
46. Effect of Single vs Bilateral Lung Transplantation on Plasma Surfactant Protein D Levels in Idiopathic Pulmonary Fibrosis
47. Elevated Pulmonary Artery Pressure Is a Risk Factor for Primary Graft Dysfunction Following Lung Transplantation for Idiopathic Pulmonary Fibrosis
48. Micromechanics of Alveolar Edema
49. Plasma Levels of Receptor for Advanced Glycation End Products, Blood Transfusion, and Risk of Primary Graft Dysfunction
50. Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.